SUBSCRIBERS
Pfizer approaches Medivation about potential takeover: sources
Published Wed, May 4, 2016 · 09:50 PM
New York
PFIZER Inc has approached US cancer drug maker Medivation Inc to express interest in an acquisition, raising the possibility of a bid rivalling a US$9.3 billion offer by Sanofi SA, people familiar with the matter said on Tuesday.
Pfizer's approach comes less than a week after Sanofi went public with its US$52.50 per share cash offer, complaining that Medivation refused to engage. Medivation subsequently rejected …
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom
Swiss watch exports plunge as China and Hong Kong demand dries up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Billionaires selling cheap stuff get richer from inflation pain
Amazon to push cashierless shopping tech into more third-party stores, while backing off itself